Company intelligence / Profile preview

Horizon Biotechnology

Aston, Pennsylvania, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Horizon Biotechnology is a life sciences company primarily focused on the development and implementation of advanced diagnostic solutions. The company gained significant prominence for its high-capacity COVID-19 testing laboratory services, utilizing RT-PCR technology to provide rapid results for healthcare providers and organizations. Beyond infectious disease testing, Horizon Biotechnology works on integrating biotechnology innovations into clinical diagnostics to improve patient outcomes. The company operates out of the Philadelphia region, serving as a key partner for regional health systems and public health initiatives.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic testPCR
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Horizon Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Horizon Biotechnology.

Explore the full profile